Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity

Arthritis and Rheumatism
Zahir AmouraSophie Koutouzov

Abstract

To assess nucleosome plasma levels in patients with systemic lupus erythematosus (SLE) and to study the correlations with serum antinucleosome, anti-double-stranded DNA (anti-dsDNA), and antihistone antibody activities, as well as with disease activity (by the SLE Disease Activity Index [SLEDAI]). In a cross-sectional study, we assessed 58 SLE patients for their plasma nucleosome levels. Plasma nucleosome levels as well as serum antinucleosome, anti-double-stranded DNA, and antihistone antibody activities were assessed by enzyme-linked immunosorbent assay. SLE activity was evaluated using the SLEDAI: The mean (+/-SD) plasma nucleosome concentration in SLE patients was 52 +/- 159 ng/ml (range 5-1,180), and was significantly higher than that of the controls (16 +/- 8.8 ng/ml, range 8-52; P = 0.03). Thirteen of the 58 lupus patients had levels over the range of normal (defined as the control mean + 3 SD, or 42 ng/ml). An inverse correlation was found between nucleosome plasma levels and serum antinucleosome antibody activity in the entire group of SLE patients, those with active disease, and those with inactive disease, respectively. No correlation was found between the SLEDAI and nucleosome plasma concentrations. Nucleosome plasm...Continue Reading

References

Aug 1, 1975·The Journal of Clinical Investigation·C R Steinman
Jul 1, 1991·European Journal of Immunology·M Monestier
Jul 1, 1990·The Journal of Clinical Investigation·P M Rumore, C R Steinman
Mar 7, 1989·Biochemistry·T D YagerK E van Holde
Feb 1, 1988·Kidney International·G J Fournié
Apr 1, 1973·The Journal of Clinical Investigation·R J HarbeckR I Carr
Mar 1, 1984·The Journal of Clinical Investigation·C R Steinman
Apr 1, 1982·Arthritis and Rheumatism·M GioudJ C Monier
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
Dec 1, 1980·The Journal of Clinical Investigation·L Raptis, H A Menard
Sep 1, 1995·Kidney International·W J TaxJ H Berden
May 1, 1995·Kidney International·G N CoritsidisP M Rumore
Jul 1, 1994·The Journal of Clinical Investigation·R W BurlingameR L Rubin
Apr 1, 1993·The Journal of Clinical Investigation·R W BurlingameA N Theofilopoulos
May 1, 1993·The Journal of Experimental Medicine·C MohanS K Datta
Sep 15, 1996·The Journal of Clinical Investigation·J B LefkowithM Gourley
Jan 1, 1997·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·M C van BruggenJ H Berden

❮ Previous
Next ❯

Citations

Dec 14, 2002·Annals of the Rheumatic Diseases·Peter J Charles
Mar 19, 2003·The Journal of Experimental Medicine·Lynda BennettVirginia Pascual
May 25, 2006·Critical Care : the Official Journal of the Critical Care Forum·Sacha Zeerleder
May 6, 2011·Arthritis Research & Therapy·Annica HedbergOle Petter Rekvig
Apr 13, 2018·International Angiology : a Journal of the International Union of Angiology·Trung PhanVinod Bansal
May 20, 2008·Clinical Chemistry·Ugur DeligezerNejat Dalay
Aug 24, 1999·Current Opinion in Nephrology and Hypertension·J H BerdenW J Tax
Aug 30, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sacha ZeerlederLucien A Aarden
Jan 12, 2005·Clinical and Diagnostic Laboratory Immunology·Krisztina SallaiPeter Gergely
May 14, 1999·Arthritis and Rheumatism·Z AmouraS Koutouzov
Sep 16, 2000·Current Opinion in Rheumatology·Z AmouraJ C Piette
Aug 28, 2001·Clinical Chemistry and Laboratory Medicine : CCLM·S HoldenriederD Seidel
Aug 2, 2001·Nature Genetics·K YasutomoY Kuroda
Nov 16, 2001·Annals of the New York Academy of Sciences·S HoldenriederD Seidel
Mar 15, 2003·Scandinavian Journal of Rheumatology·Maurizio BenucciFabrizio Cantini
Feb 12, 2004·Journal of Internal Medicine·F D'AuriaM G Sabbadini
Jun 15, 2006·Antioxidants & Redox Signaling·Ryszard OlinskiMarcus S Cooke
Nov 23, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Viktoria M RönnefarthPatrice Decker
Dec 25, 2008·Critical Reviews in Clinical Laboratory Sciences·Stefan Holdenrieder, Petra Stieber
Oct 20, 2009·Autoimmunity·Kristin Andreassen FentonOle Petter Rekvig
Sep 23, 2009·Laboratory Investigation; a Journal of Technical Methods and Pathology·Wendy Anne BoivinDavid James Granville
May 1, 2006·Expert Review of Clinical Immunology·Jessica J Manson, David A Isenberg
Apr 9, 2010·International Journal of Rheumatic Diseases·Suleiman SuleimanChe Hussin Che Maraina
Feb 5, 2016·Nature Reviews. Rheumatology·Steven O'Reilly, Jacob M van Laar
Feb 20, 2016·Journal of Intensive Care·Anne K PenttiläHeikki Repo
Apr 3, 2019·Nature Microbiology·Camille HallezJean-Pierre Vartanian
Mar 10, 2005·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Andreas KremerDietrich Seidel
Apr 15, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Concepción GonzálezJosé Manuel González-Buitrago
Jul 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sylvie FournelSylviane Muller
Nov 17, 2006·Annals of the New York Academy of Sciences·Stefan HoldenriederPetra Stieber

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.